• Pharma
  • April 8, 2025
  • 305 views
Aurobindo Pharma arm gets European Commission authorization to market Dyrupeg in EU

Telangana:  Aurobindo Pharma has announced that the European Commission (EC) has granted marketing authorization in the European Union (EU) for Dyrupeg, a pegylated filgrastim biosimilar, to CuraTeQ Biologics s.r.o., a…